Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1988-05

AUTHORS

B M Foxwell, H A Band, J Long, W A Jeffery, D Snook, P E Thorpe, G Watson, P J Parker, A A Epenetos, A M Creighton

ABSTRACT

In recent years, radiolabelled monoclonal antibodies have been evaluated for their use in the diagnosis and treatment of neoplastic disease. One isotope which has not been assessed for antibody targeting is 32P, even though it has many favourable radiobiological characteristics and has been used clinically for the treatment of certain neoplastic disorders such as polycythaemia rubra vera. The main drawback so far in using 32P has been the absence of a general method for phosphorylating antibodies. We have now developed a novel process for the phosphorylation of immunoglobulins which is rapid, efficient and allows high specific activities to be achieved (greater than 10 muCi micrograms-1). The technique involves the chemical conjugation of Kemptide, a synthetic heptapeptide substrate for kinases, to immunoglobulins. The antibody-Kemptide conjugate can then be phosphorylated using protein kinases and [32P]-gamma-ATP. The procedure does not compromise the binding activity of the antibody. The 32P-labelled monoclonal antibodies were stable in human, mouse and rat plasmas in vitro, although they cleared from the bloodstream of mice with a beta-phase half life of 2 days which is approximately two times faster than that of native antibody. The application of this phosphorylation technique should allow the therapeutic potential of targeted 32P to be assessed. More... »

PAGES

489

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1988.112

DOI

http://dx.doi.org/10.1038/bjc.1988.112

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008596383

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3395553


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigen-Antibody Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isotope Labeling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligopeptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorus Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research UK", 
          "id": "https://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Department of Cellular Pharmacology, Imperial Cancer Research Fund, London, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Foxwell", 
        "givenName": "B M", 
        "id": "sg:person.01030652614.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030652614.03"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Band", 
        "givenName": "H A", 
        "type": "Person"
      }, 
      {
        "familyName": "Long", 
        "givenName": "J", 
        "type": "Person"
      }, 
      {
        "familyName": "Jeffery", 
        "givenName": "W A", 
        "id": "sg:person.0637072031.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637072031.03"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Snook", 
        "givenName": "D", 
        "id": "sg:person.0714627557.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714627557.25"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Thorpe", 
        "givenName": "P E", 
        "id": "sg:person.01112075764.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112075764.02"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Watson", 
        "givenName": "G", 
        "id": "sg:person.01263307427.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263307427.21"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Parker", 
        "givenName": "P J", 
        "id": "sg:person.01111564441.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111564441.81"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Epenetos", 
        "givenName": "A A", 
        "id": "sg:person.016222741744.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016222741744.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Creighton", 
        "givenName": "A M", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0022-1759(83)90311-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015137519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(83)90311-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015137519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(86)90110-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015231633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(78)90135-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015737366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(78)90135-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015737366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004424-198207000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019010155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004424-198207000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019010155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0076-6879(74)38046-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019134092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0003-2697(83)90343-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031778004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj1730723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037949966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj1730723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037949966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000225543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048315995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci111175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051672558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.290.6480.1463", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052748286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0020-708x(84)90106-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053409846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0020-708x(84)90106-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053409846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.6836304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062640944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.7199757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062644387"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/0007-1285-57-677-395", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064554899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080068859", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080102679", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081656868", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1988-05", 
    "datePublishedReg": "1988-05-01", 
    "description": "In recent years, radiolabelled monoclonal antibodies have been evaluated for their use in the diagnosis and treatment of neoplastic disease. One isotope which has not been assessed for antibody targeting is 32P, even though it has many favourable radiobiological characteristics and has been used clinically for the treatment of certain neoplastic disorders such as polycythaemia rubra vera. The main drawback so far in using 32P has been the absence of a general method for phosphorylating antibodies. We have now developed a novel process for the phosphorylation of immunoglobulins which is rapid, efficient and allows high specific activities to be achieved (greater than 10 muCi micrograms-1). The technique involves the chemical conjugation of Kemptide, a synthetic heptapeptide substrate for kinases, to immunoglobulins. The antibody-Kemptide conjugate can then be phosphorylated using protein kinases and [32P]-gamma-ATP. The procedure does not compromise the binding activity of the antibody. The 32P-labelled monoclonal antibodies were stable in human, mouse and rat plasmas in vitro, although they cleared from the bloodstream of mice with a beta-phase half life of 2 days which is approximately two times faster than that of native antibody. The application of this phosphorylation technique should allow the therapeutic potential of targeted 32P to be assessed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1988.112", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "57"
      }
    ], 
    "name": "Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P", 
    "pagination": "489", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "28f4989de5210cc3b431b4d68e6a5e2e9747929aa1beb1ef280267d94de55ecc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3395553"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1988.112"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008596383"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1988.112", 
      "https://app.dimensions.ai/details/publication/pub.1008596383"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53981_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc1988112"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.112'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.112'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.112'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.112'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      21 PREDICATES      57 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1988.112 schema:about N0d1da1bb5d084370a4fc836f6f4a152f
2 N2273efab22794f0799152d8bc98dfb10
3 N2645ad717bfe4f4a90ac356aa8aade4e
4 N3f431ac97928489dbeb544fd434b2c65
5 N83a94d4848f44bc198d9722c19f172a6
6 N9a48f777b82346639d6db735a2075ea8
7 Nbd3644765ca747ad9105d8be1e7867a9
8 Nc2bacc2889ee4829a85609f8a34740c1
9 Nc376198bcbf74959902e9cf3f417804d
10 Nea3745ef64734364b6afe06a8a989649
11 Nf2824ed987bb41c88d9f73b3409b70e4
12 anzsrc-for:11
13 anzsrc-for:1107
14 schema:author Neec50fdae0874cbab5197e66845eef7b
15 schema:citation https://app.dimensions.ai/details/publication/pub.1080068859
16 https://app.dimensions.ai/details/publication/pub.1080102679
17 https://app.dimensions.ai/details/publication/pub.1081656868
18 https://doi.org/10.1016/0003-2697(83)90343-3
19 https://doi.org/10.1016/0020-708x(84)90106-6
20 https://doi.org/10.1016/0022-1759(78)90135-7
21 https://doi.org/10.1016/0022-1759(83)90311-3
22 https://doi.org/10.1016/0076-6879(74)38046-9
23 https://doi.org/10.1016/0360-3016(86)90110-0
24 https://doi.org/10.1042/bj1730723
25 https://doi.org/10.1097/00004424-198207000-00007
26 https://doi.org/10.1126/science.6836304
27 https://doi.org/10.1126/science.7199757
28 https://doi.org/10.1136/bmj.290.6480.1463
29 https://doi.org/10.1159/000225543
30 https://doi.org/10.1172/jci111175
31 https://doi.org/10.1259/0007-1285-57-677-395
32 schema:datePublished 1988-05
33 schema:datePublishedReg 1988-05-01
34 schema:description In recent years, radiolabelled monoclonal antibodies have been evaluated for their use in the diagnosis and treatment of neoplastic disease. One isotope which has not been assessed for antibody targeting is 32P, even though it has many favourable radiobiological characteristics and has been used clinically for the treatment of certain neoplastic disorders such as polycythaemia rubra vera. The main drawback so far in using 32P has been the absence of a general method for phosphorylating antibodies. We have now developed a novel process for the phosphorylation of immunoglobulins which is rapid, efficient and allows high specific activities to be achieved (greater than 10 muCi micrograms-1). The technique involves the chemical conjugation of Kemptide, a synthetic heptapeptide substrate for kinases, to immunoglobulins. The antibody-Kemptide conjugate can then be phosphorylated using protein kinases and [32P]-gamma-ATP. The procedure does not compromise the binding activity of the antibody. The 32P-labelled monoclonal antibodies were stable in human, mouse and rat plasmas in vitro, although they cleared from the bloodstream of mice with a beta-phase half life of 2 days which is approximately two times faster than that of native antibody. The application of this phosphorylation technique should allow the therapeutic potential of targeted 32P to be assessed.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N1f96a0a6ac904fe4a579d23d98a0a7be
39 N2416d073c3554eb68c37b06b28e59844
40 sg:journal.1017082
41 schema:name Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P
42 schema:pagination 489
43 schema:productId N028624f4575c4eb992a586bbbc48a6fa
44 N2d5ee2764539429487e238080afb9cc7
45 N36fa2f46c167490ea8533504d912c55d
46 N5a2d9486cea2488cbd1af4211b26076a
47 N8b4b65c231784359a678effbf305f39d
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008596383
49 https://doi.org/10.1038/bjc.1988.112
50 schema:sdDatePublished 2019-04-11T12:11
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N349afd385d2a4693af7db074f0fadf8f
53 schema:url https://www.nature.com/articles/bjc1988112
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N028624f4575c4eb992a586bbbc48a6fa schema:name doi
58 schema:value 10.1038/bjc.1988.112
59 rdf:type schema:PropertyValue
60 N085a2e81f3f24463966dac6ccd8ca6d0 rdf:first N415e4cbfbbcd428793b163f05cb0be5c
61 rdf:rest N5bd8f48242ff4fdeb19559f6740fea90
62 N0d1da1bb5d084370a4fc836f6f4a152f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Isotope Labeling
64 rdf:type schema:DefinedTerm
65 N1f96a0a6ac904fe4a579d23d98a0a7be schema:issueNumber 5
66 rdf:type schema:PublicationIssue
67 N2273efab22794f0799152d8bc98dfb10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Mice
69 rdf:type schema:DefinedTerm
70 N241638d840704ab1b8742ce157faff73 rdf:first sg:person.01263307427.21
71 rdf:rest N6ae1c941ef704594978af299396ca5d4
72 N2416d073c3554eb68c37b06b28e59844 schema:volumeNumber 57
73 rdf:type schema:PublicationVolume
74 N2645ad717bfe4f4a90ac356aa8aade4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Animals
76 rdf:type schema:DefinedTerm
77 N2d5ee2764539429487e238080afb9cc7 schema:name nlm_unique_id
78 schema:value 0370635
79 rdf:type schema:PropertyValue
80 N349afd385d2a4693af7db074f0fadf8f schema:name Springer Nature - SN SciGraph project
81 rdf:type schema:Organization
82 N36fa2f46c167490ea8533504d912c55d schema:name pubmed_id
83 schema:value 3395553
84 rdf:type schema:PropertyValue
85 N3f431ac97928489dbeb544fd434b2c65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Antigen-Antibody Reactions
87 rdf:type schema:DefinedTerm
88 N415e4cbfbbcd428793b163f05cb0be5c schema:familyName Band
89 schema:givenName H A
90 rdf:type schema:Person
91 N5a2d9486cea2488cbd1af4211b26076a schema:name readcube_id
92 schema:value 28f4989de5210cc3b431b4d68e6a5e2e9747929aa1beb1ef280267d94de55ecc
93 rdf:type schema:PropertyValue
94 N5bd8f48242ff4fdeb19559f6740fea90 rdf:first Ncdb42b2491494dbf9e15e572a758bafc
95 rdf:rest Nabe5c6d9c9f246aaade48103160118a0
96 N67bb892ea78048dd8c920d48b4548c1c rdf:first sg:person.01112075764.02
97 rdf:rest N241638d840704ab1b8742ce157faff73
98 N6ae1c941ef704594978af299396ca5d4 rdf:first sg:person.01111564441.81
99 rdf:rest Nf810d56c630d447b9c47d1573044b1a9
100 N83a94d4848f44bc198d9722c19f172a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Oligopeptides
102 rdf:type schema:DefinedTerm
103 N8b4b65c231784359a678effbf305f39d schema:name dimensions_id
104 schema:value pub.1008596383
105 rdf:type schema:PropertyValue
106 N9a48f777b82346639d6db735a2075ea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Phosphorus Radioisotopes
108 rdf:type schema:DefinedTerm
109 Na5d3de1f41af4e88b890bbb91bb157a7 rdf:first Nee455bd9a7894f9d9ab67e1a59cf411a
110 rdf:rest rdf:nil
111 Nabe5c6d9c9f246aaade48103160118a0 rdf:first sg:person.0637072031.03
112 rdf:rest Ndaab9d3adaee49f08adf7d318a4e804b
113 Nbd3644765ca747ad9105d8be1e7867a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Antibodies, Monoclonal
115 rdf:type schema:DefinedTerm
116 Nc2bacc2889ee4829a85609f8a34740c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Phosphorylation
118 rdf:type schema:DefinedTerm
119 Nc376198bcbf74959902e9cf3f417804d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Protein Kinases
121 rdf:type schema:DefinedTerm
122 Ncdb42b2491494dbf9e15e572a758bafc schema:familyName Long
123 schema:givenName J
124 rdf:type schema:Person
125 Ndaab9d3adaee49f08adf7d318a4e804b rdf:first sg:person.0714627557.25
126 rdf:rest N67bb892ea78048dd8c920d48b4548c1c
127 Nea3745ef64734364b6afe06a8a989649 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 Nee455bd9a7894f9d9ab67e1a59cf411a schema:familyName Creighton
131 schema:givenName A M
132 rdf:type schema:Person
133 Neec50fdae0874cbab5197e66845eef7b rdf:first sg:person.01030652614.03
134 rdf:rest N085a2e81f3f24463966dac6ccd8ca6d0
135 Nf2824ed987bb41c88d9f73b3409b70e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Mice, Inbred BALB C
137 rdf:type schema:DefinedTerm
138 Nf810d56c630d447b9c47d1573044b1a9 rdf:first sg:person.016222741744.55
139 rdf:rest Na5d3de1f41af4e88b890bbb91bb157a7
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
144 schema:name Immunology
145 rdf:type schema:DefinedTerm
146 sg:journal.1017082 schema:issn 0007-0920
147 1532-1827
148 schema:name British Journal of Cancer
149 rdf:type schema:Periodical
150 sg:person.01030652614.03 schema:affiliation https://www.grid.ac/institutes/grid.11485.39
151 schema:familyName Foxwell
152 schema:givenName B M
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030652614.03
154 rdf:type schema:Person
155 sg:person.01111564441.81 schema:familyName Parker
156 schema:givenName P J
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111564441.81
158 rdf:type schema:Person
159 sg:person.01112075764.02 schema:familyName Thorpe
160 schema:givenName P E
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112075764.02
162 rdf:type schema:Person
163 sg:person.01263307427.21 schema:familyName Watson
164 schema:givenName G
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263307427.21
166 rdf:type schema:Person
167 sg:person.016222741744.55 schema:familyName Epenetos
168 schema:givenName A A
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016222741744.55
170 rdf:type schema:Person
171 sg:person.0637072031.03 schema:familyName Jeffery
172 schema:givenName W A
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637072031.03
174 rdf:type schema:Person
175 sg:person.0714627557.25 schema:familyName Snook
176 schema:givenName D
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714627557.25
178 rdf:type schema:Person
179 https://app.dimensions.ai/details/publication/pub.1080068859 schema:CreativeWork
180 https://app.dimensions.ai/details/publication/pub.1080102679 schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1081656868 schema:CreativeWork
182 https://doi.org/10.1016/0003-2697(83)90343-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031778004
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/0020-708x(84)90106-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053409846
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/0022-1759(78)90135-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015737366
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/0022-1759(83)90311-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015137519
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/0076-6879(74)38046-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019134092
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/0360-3016(86)90110-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015231633
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1042/bj1730723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037949966
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1097/00004424-198207000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019010155
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1126/science.6836304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062640944
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1126/science.7199757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062644387
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1136/bmj.290.6480.1463 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052748286
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1159/000225543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048315995
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1172/jci111175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051672558
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1259/0007-1285-57-677-395 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064554899
209 rdf:type schema:CreativeWork
210 https://www.grid.ac/institutes/grid.11485.39 schema:alternateName Cancer Research UK
211 schema:name Department of Cellular Pharmacology, Imperial Cancer Research Fund, London, UK.
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...